Blog

Read our latest blog posts on biotech, AI, and funding rare disease research.

April 23, 2025

Pharma’s business development and licensing (BD&L) teams are at the forefront of identifying new science to support their company’s future.

April 7, 2025

Biopharma business development and scientific teams are under a lot of pressure to identify the next big program for their

March 20, 2025

I recently sat down with a Top 20 pharmaceutical company to discuss their goals and struggles for the year ahead

March 5, 2025

Recently, I had a conversation with Dr. Kanya Rajangam, to discuss current perceptions about Chinese biotech, opportunities, language challenges,

March 3, 2025

Chinese biopharma companies are at an inflection point, with rapidly advancing in science, know-how, + talent. Chinese assets are poised

January 29, 2025

Based on JPM 2025, it’s safe to say that the biotech industry is experiencing a broad resurgence, with subtle yet